Keryx / AOI Pharmaceuticals, Inc.
1 clinical trials · Sponsor
◉ Watch Keryx / AOI Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic Glioma (NCT00389090) | Keryx / AOI Pharmaceuticals, Inc. | 2006-10-01 |
Track Keryx / AOI Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.